Isotope-Labeled Compounds
Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time.
MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.
All Product Categories
-
Isotope-Labeled Compounds Related Products (11128)
Related Products (11128)
-
Enasidenib-d6
0 ImagesCat. No.: HY-18690SCAS No.: 2095569-76-7Synonyms: AG-221-d6Enasidenib-d6 (AG-221-d6) is the deuterium labeled Enasidenib (HY-18690). Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.
-
4-tert-Butylbenzoic acid-d13
0 ImagesCat. No.: HY-W746299Synonyms: p-tert-Butylbenzoic acid-d134-?tert-?Butylbenzoic acid-d13 (p-tert-Butylbenzoic acid-d13) is the deuterium labeled 4-(tert-Butyl)benzoic acid.
-
Oxazepam acetate-d5
0 ImagesCat. No.: HY-W743488CAS No.: 65854-77-5Oxazepam acetate-d5 is the deuterium labeled Oxazepam acetate.
-
4-Hydroxybenzhydrazide-d4
0 ImagesCat. No.: HY-W738939CAS No.: 2733719-85-04-Hydroxybenzhydrazide-d4 is the deuterium labeled 4-Hydroxybenzohydrazide (HY-W012579).
-
2'-O-Methyladenosine-d
0 ImagesCat. No.: HY-W011552S2'-O-Methyladenosine-d is the deuterium labeled 2'-O-Methyladenosine (HY-W011552). 2'-O-Methyladenosine, a methylated adenine residue is found in urine of normals as well as in urine of adenosine deaminase (ADA) deficient patients. 2'-O-Methyladenosine exhibits unique hypotensive activities.
-
D-Arabinose Phenylhydrazone-13C5
0 ImagesCat. No.: HY-W746880D-Arabinose Phenylhydrazone-13C5 is the 13C-labeled D-Arabinose Phenylhydrazone.
-
Rupatadine-d4 fumarate
0 ImagesCat. No.: HY-13511ASCAS No.: 1795153-63-7Synonyms: UR-12592 D4 fumarateRupatadine-d4 fumarate is a deuterium labeled Rupatadine fumarate. Rupatadine Fumarate (UR-12592 Fumarate) is a potent dual PAF/H1 antagonist with Ki values of 0.55/0.1 μM (rabbit platelet membranes/guinea pig cerebellum membranes).
-
(S)-(+)-Ketoprofen-13C,d3
0 ImagesCat. No.: HY-W778002CAS No.: 1330260-99-5(S)-(+)-Ketoprofen-13C,d3 is the deuterium and 13C-labeled S-(+)-Ketoprofen (HY-B2137). S-(+)-Ketoprofen is a potent inhibitor of both COX-1 and COX-2 with IC50s of 1.9 and 27 nM, respectively.
-
4-Desacetamido-4-fluoro Andarine-d4
0 ImagesCat. No.: HY-W7445924-Desacetamido-4-fluoro Andarine-d4 is deuterium-labeled 4-Desacetamido-4-fluoro Andarine.
-
L-Valine-13C5,15N,d2
0 ImagesCat. No.: HY-N0717S3CAS No.: 201417-09-6Synonyms: (S)-Valine-13C5,15N,d2L-Valine-13C5,15N,d2 ((S)-Valine-13C5,15N,d2) is the deuterium, 13C-, and 15N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase.
-
4-(Dimethylamino)benzoic-2,3,5,6-d4 acid
0 ImagesCat. No.: HY-W720442CAS No.: 1175002-07-94-(Dimethylamino)benzoic-2,3,5,6-d4 acid is the deuterium labeled 4-Dimethylaminobenzoic acid (HY-W018790).
-
N-Acetyl-DL-alanine-d7
0 ImagesCat. No.: HY-W010389SN-Acetyl-DL-alanine-d7 is the deuterium labeled N-Acetyl-DL-alanine.
-
(Allyloxy)benzene-d5
0 ImagesCat. No.: HY-W709873CAS No.: 1373735-60-4Synonyms: Allylphenylether-d5(Allyloxy)benzene-d5 (Allylphenylether-d5) is the deuterium labeled (Allyloxy)benzene,98% (stabilized with MEHQ) (HY-W012655).
-
2,4-Difluorobenzoic acid-d3
0 Images2,4-Difluorobenzoic acid-d3 is the deuterated-labeled 2,4-Difluorobenzoic acid (HY-W002068). 2,4-Difluorobenzoic acid is a difluorinated aromatic carboxylic acid. 2,4-Difluorobenzoic acid can serve as a crystalline molecular ruler for fluorine-fluorine distance measurements by 19F MAS NMR, as well as a non-radioactive passive water tracer for oilfield applications.
-
H-Gly-OBzl.TosOH-13C2,15N
0 ImagesCat. No.: HY-W779904CAS No.: 874462-68-7H-Gly-OBzl.TosOH-13C2,15N is the 13C- and 15N-labeled H-Gly-OBzl.TosOH (HY-W011200). H-Gly-OBzl.TosOH is a Glycine (HY-Y0966) derivative.
-
Dihydrolanosterol-d7
0 ImagesDihydrolanosterol-d7 is deuterium labeled Dihydrolanosterol. Dihydrolanosterol is a subtrate of CYP51 and a cholesterol biosynthesis inhibitor.
-
Rabeprazole sulfide-d4
0 ImagesCat. No.: HY-W719463Rabeprazole sulfide-d4 is the deuterium labeled Rabeprazole Sulfide (HY-W003467). Rabeprazole Sulfide is an active metabolite of Rabeprazole. Rabeprazole is a proton pump inhibitor that suppresses gastric acid secretion through an interaction with (H+/K+)-ATPase in gastric parietal cells. Rabeprazole markedly inhibits the motility of H. pylori. Rabeprazole has the potential for various peptic diseases treatment.
-
Amoxicillin-13C6
0 ImagesCat. No.: HY-B0467ASSynonyms: Amoxycillin-13C6Amoxicillin-13C6 is the 13C6 labeled Amoxicillin. Amoxicillin is an antibiotic with good oral absorption and broad spectrum antimicrobial activity.
-
Avanafil-13C5,15N,d2
0 ImagesCat. No.: HY-18252S1Avanafil-13C5,15N,d2 is 15N and deuterated labeled Avanafil (HY-18252). Avanafil (TA-1790) is a potent and selective phosphodiesterase-5 (PDE-5) inhibitor with IC50 values of 5.2 nM, 630 nM, 5700 nM, 6200 nM, 12000 nM, 27000 nM, 51000 nM and 53000 nM for PDE-5, PDE-6, PDE-4, PDE-10, PDE-8, PDE-7, PDE-2 and PDE-1, respectively. Avanafil activates NO/cGMP/PKG signaling-pathway to decrease loss in BMD, bone atrophy, and oxidative stress. Avanafil inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels. Avanafil can be used for the research of erectile dysfunction and osteoporosis.
